Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,276
archived clinical trials in
Pancreatic Cancer

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Rhode Island Hospital
mi
from
Providence, RI
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Medical University of South Carolina
mi
from
Charleston, SC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Vermont Cancer Center
mi
from
Burlington, VT
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Vermont Cancer Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Proton Radiation for Resectable Carcinoma of the Pancreas
A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
Status: Enrolling
Updated:  11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Proton Radiation for Resectable Carcinoma of the Pancreas
A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
Status: Enrolling
Updated: 11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  11/17/2016
Provision Proton Therapy Center
mi
from
Knoxville, TN
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 11/17/2016
Provision Proton Therapy Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pancreatic Resection, Malnutrition and Readmission
Pancreatic Resection, Malnutrition, and Readmission: Assessment and Prevention
Status: Enrolling
Updated:  11/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Pancreatic Resection, Malnutrition and Readmission
Pancreatic Resection, Malnutrition, and Readmission: Assessment and Prevention
Status: Enrolling
Updated: 11/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Prospective Phase I Study of Gax (Gemcitabine, ABRAXANE, and Xeloda) for Metastatic Pancreatic Cancer Protocol # TSH - APG - 2015-01
Status: Enrolling
Updated:  12/5/2016
Stamford Hospital, Bennett Cancer Center
mi
from
Stamford, CT
Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Prospective Phase I Study of Gax (Gemcitabine, ABRAXANE, and Xeloda) for Metastatic Pancreatic Cancer Protocol # TSH - APG - 2015-01
Status: Enrolling
Updated: 12/5/2016
Stamford Hospital, Bennett Cancer Center
mi
from
Stamford, CT
Click here to add this to my saved trials
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated:  12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated: 12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Pilot Study of Gemcitabine, Oxaliplatin, and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Pilot Study of Gemcitabine, Oxaliplatin, and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/19/2016
Massachusetts General Hospital
mi
from
Boston, MA
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/19/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/19/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/19/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/19/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/19/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Creation of the BioBank, Early Detection and Discovery Biomarkers
Creation of the BioBank,To Establish a Multidisciplinary Research Structure That Facilitates Projects That Bridge Specialties That Normally May or May Not Interact.
Status: Enrolling
Updated:  1/5/2017
William Beaumont Hospitals
mi
from
Royal Oak, MI
Creation of the BioBank, Early Detection and Discovery Biomarkers
Creation of the BioBank,To Establish a Multidisciplinary Research Structure That Facilitates Projects That Bridge Specialties That Normally May or May Not Interact.
Status: Enrolling
Updated: 1/5/2017
William Beaumont Hospitals
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  1/11/2017
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 1/11/2017
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated:  1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated: 1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Gemcitabine and Abraxane for Pancreas Cancer
A Phase II Study of Gemcitabine and Nanoparticle-Bound Paclitaxel as Second Line Therapy in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  2/13/2017
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington,
Study of Gemcitabine and Abraxane for Pancreas Cancer
A Phase II Study of Gemcitabine and Nanoparticle-Bound Paclitaxel as Second Line Therapy in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 2/13/2017
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Status: Enrolling
Updated:  2/13/2017
Florida Hospital
mi
from
Orlando, FL
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Status: Enrolling
Updated: 2/13/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  3/2/2017
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 3/2/2017
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated:  4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated: 4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Click here to add this to my saved trials
EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
Status: Enrolling
Updated:  4/25/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
Status: Enrolling
Updated: 4/25/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated:  5/15/2017
Site US116
mi
from
Madison, WI
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated: 5/15/2017
Site US116
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated:  5/15/2017
Site CA00203
mi
from
Toronto,
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated: 5/15/2017
Site CA00203
mi
from
Toronto,
Click here to add this to my saved trials
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer
Status: Enrolling
Updated:  5/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer
Status: Enrolling
Updated: 5/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Assessing the Clinical Significance of Real-time Quality of Life Data in Cancer Patients Treated With Radiation Therapy
Status: Enrolling
Updated:  5/23/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Assessing the Clinical Significance of Real-time Quality of Life Data in Cancer Patients Treated With Radiation Therapy
Status: Enrolling
Updated: 5/23/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Status: Enrolling
Updated:  6/1/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Status: Enrolling
Updated: 6/1/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery
Cytopathologic Margin Evaluation in Patients Undergoing Pancreatic Cancer Resection
Status: Enrolling
Updated:  6/8/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery
Cytopathologic Margin Evaluation in Patients Undergoing Pancreatic Cancer Resection
Status: Enrolling
Updated: 6/8/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Genetic Evaluation of Families With Endocrine Cancers
A Pilot Study of Genetic Evaluation of Families With Endocrine Cancers
Status: Enrolling
Updated:  6/15/2017
Jersey Shore University Medical Center
mi
from
Neptune City, NJ
Genetic Evaluation of Families With Endocrine Cancers
A Pilot Study of Genetic Evaluation of Families With Endocrine Cancers
Status: Enrolling
Updated: 6/15/2017
Jersey Shore University Medical Center
mi
from
Neptune City, NJ
Click here to add this to my saved trials
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/18/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/18/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/18/2017
Massachusetts General Hospital
mi
from
Boston, MA
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/18/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/18/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/18/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/18/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/18/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/18/2017
Washington University
mi
from
Saint Louis, MO
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/18/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
Surgical Outcomes Database for Faculty of Hepatopancreatico Biliary Surgery
Status: Enrolling
Updated:  7/31/2017
Carolinas Health System
mi
from
Charlotte, NC
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
Surgical Outcomes Database for Faculty of Hepatopancreatico Biliary Surgery
Status: Enrolling
Updated: 7/31/2017
Carolinas Health System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Status: Enrolling
Updated:  7/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Status: Enrolling
Updated: 7/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions
A Randomized Trial Evaluating the Number of Passes Required for Diagnostic Cell Block During Endoscopic Ultrasound-Fine Needle Aspiration of Solid Pancreatic Mass Lesions
Status: Enrolling
Updated:  8/2/2017
Florida Hospital
mi
from
Orlando, FL
Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions
A Randomized Trial Evaluating the Number of Passes Required for Diagnostic Cell Block During Endoscopic Ultrasound-Fine Needle Aspiration of Solid Pancreatic Mass Lesions
Status: Enrolling
Updated: 8/2/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
Randomized Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
Status: Enrolling
Updated:  8/2/2017
Florida Hospital
mi
from
Orlando, FL
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
Randomized Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
Status: Enrolling
Updated: 8/2/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  8/7/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 8/7/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  8/7/2017
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 8/7/2017
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  8/7/2017
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 8/7/2017
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
Expression Patterns of Stem Cell Marker Doublecortin and CaM Kinase-Like-1 (DCAMKL-1) in Human Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  8/21/2017
Stephensen Cancer Center
mi
from
Oklahoma City, OK
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
Expression Patterns of Stem Cell Marker Doublecortin and CaM Kinase-Like-1 (DCAMKL-1) in Human Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 8/21/2017
Stephensen Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated:  8/28/2017
Emory University Hospital
mi
from
Atlanta, GA
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated: 8/28/2017
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated:  8/28/2017
North Shore-LIJ Health System
mi
from
Manhasset, NY
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated: 8/28/2017
North Shore-LIJ Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated:  8/28/2017
Columbia University Medical Center
mi
from
New York, NY
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated: 8/28/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated:  8/28/2017
Temple University Hospital
mi
from
Philadelphia, PA
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Status: Enrolling
Updated: 8/28/2017
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials